In this Fall edition of Surgical Oncology Rounds, James P. Celebrezze, Jr., MD, FACS, FASCRS reviews rectal cancer care in the 21st century.
Samer T. Tohme, MD, explains how robotic liver surgery is taking liver cancer surgery to new levels.
Udai S. Kammula, MD, FACS, presents how Adoptive Cell Transfer Immunotherapy has several potential advantages over other immunotherapeutic approaches to treat cancer. Dr. Kammula reviews clinical trials, where cutaneous and uveal melanomas responded to this innovative approach.
Atilla Soran, MD, MPH, FACS, discusses the value of primary surgery in metastatic breast cancer survival.
Alessandro Paniccia, MD, explains Exosomal DNA and miRNA and identifies biomarkers predicting response to Neoadjuvant chemotherapy and recurrence in Pancreatic Ductal Adenocarcinoma.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Recognize the existence of variability in rectal cancer care and ways to improve the care given
- Recall adoptive cell transfer clinical trials
- Describe the multidisciplinary decision of loco-regional treatment in metastatic breast cancer at presentation
- Identify Indications for robotic liver resection
- Explain the role of liquid biopsies in neo-adjuvant therapies for patients with localized pancreatic ductal adenocarcinoma
Disclosures
Drs. Celebrezze, Tohme have reported no relevant relationships with entities producing health care goods or services.
Dr. Kammula has financial interests with the following entity or entities producing health care goods or services as indicated below:
- Received a research grant from the NIH R01, and received ITTC intramural funding
Dr. Paniccia has financial interests with the following entity or entities producing health care goods or services as indicated below:
- Received a research grant from the National Pancreas Foundation
Dr. Soran has financial interests with the following entity or entities producing health care goods or services as indicated below:
- Serves as a consultant for ImpediMed®
All presenters' disclosures of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers, and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation Statement
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates enduring material activity for a maximum of .50 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
For your credit transcript, please access our website four weeks postcompletion at http://ccehs.upmc.com and follow the link to the Credit Transcript page.
Release Date: 11/24/2020 | Last Modified On: 11/25/2020 | Expires: 11/24/2021
